RegeneronOvjeren akaunt

@Regeneron

Official channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here

Tarrytown, NY
Vrijeme pridruživanja: ožujak 2009.

Tweetovi

Blokirali ste korisnika/cu @Regeneron

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Regeneron

  1. Prikvačeni tweet
    22. sij

    👏 With , we’re introducing the 2020 finalists! These bright young minds are the top 40 contenders from nearly 2,000 applicants with research projects focused on beehive protection, clean water and greenhouse light. Read on: .

    Poništi
  2. Tune in for our Q4 earnings call at 8am ET today:

    Poništi
  3. There are many steps taken to create our medicines. The team uses cutting-edge technology to develop, optimize, validate and license the complex manufacturing processes required to produce life-changing medicines for people around the world. 👩‍🔬👨‍🔬

    Poništi
  4. 4. velj

    Our colleagues are dedicated to making a difference for patients. This , Israel Lowy, SVP of Translational Science & Clinical Oncology, explains how we are researching new ways to use bispecific :

    Poništi
  5. 4. velj

    Don’t miss our Q4 earnings call on Thursday at 8 am ET: .

    Poništi
  6. 4. velj

    Announcing our expanded collaboration with to develop new potential antibody medicines for the novel . Learn more: .

    Poništi
  7. 3. velj

    The is… pathogen: a disease-causing microorganism, such as a virus or bacteria.

    Poništi
  8. 31. sij

    : The new is an interactive educational center equipped with two state-of-the-art teaching labs. We hope to inspire future generations and look forward to hosting local school field trips! Learn more:

    Poništi
  9. 30. sij

    Drew Murphy, our EVP of Research, discusses with how scientists are harnessing the body’s natural processes to create novel antibody medicines.

    Poništi
  10. 29. sij

    Charlie’s panel discussion was a continuation of his work evaluating the utility of the polygenic risk score for cardiovascular patients, as noted in his November 2019 paper from

    Prikaži ovu nit
    Poništi
  11. 29. sij

    is always on our mind: Dr. Charles Paulding of the spoke at Friday about how to utilize polygenic risk scores to enhance clinical care.

    Prikaži ovu nit
    Poništi
  12. 28. sij

    This , we asked our Chief Privacy Officer, Ericka Watson, what she wants everyone to know about .

    Poništi
  13. 28. sij

    Not all medicines are created equal. Our deep scientific expertise allows us to develop new technologies to help discover novel antibody medicines. Learn more from our scientists:

    Poništi
  14. 28. sij

    Announcing w/ : the FDA has accepted for priority review the sBLA for our medicine for children aged 6-11 years with inadequately controlled moderate-to-severe . Read more:

    Poništi
  15. proslijedio/la je Tweet
    24. sij

    Our partners and are committed to empowering patients through education about the science and human impact of disease. At 2020, they will explore how type 2 inflammation may underlie seemingly unconnected diseases such as and

    Poništi
  16. 24. sij

    We can’t resist a good meme.

    Poništi
  17. 24. sij

    the Regeneron International Science and Engineering Fair receives more than 175,000 applications from students around the world each year, making it is the world’s largest pre-college science and engineering competition? Learn more: .

    Poništi
  18. proslijedio/la je Tweet

    Mark your calendars! 📅 Here's your chance to meet this year's finalists & their amazing 🤩 science research projects 🔬🔭!

    Ovo je potencijalno osjetljiv multimedijski sadržaj. Saznajte više
    Poništi
  19. 23. sij

    A warm welcome to the 2020 finalists! We’re proud to add 40 more to this family of bright young science heroes.

    Poništi
  20. 21. sij

    Congrats to our President and CEO Len Schleifer for being included on ’s Health Power 100 list for his leadership in the industry. Find out more: .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·